[1]NING GX,LI L,DU J,et al.Research progress of hepatic failure[J].China Med Herald,2015,12(27):42-46.(in Chinese)宁更献,李力,杜婧,等.肝衰竭的研究进展[J].中国医药导报,2015,12(27):42-46.
|
[2]Liver Failure and Artificial Liver Group,Chinese Severe Liver Diseases and Artificial Liver Group.Diagnostic and treatment guidelines for liver failure(2012 version)[J].J Pract Hepatol,2013,16(3):210-216.(in Chinese)中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2012年版)[J].实用肝脏病杂志,2013,16(3):210-216.
|
[3]ZANG H,LIU HL,HAO YQ,et al.Risk factors for infections in patients with acute-on-chronic liver failure and their influences on short-term outcome[J].Infect Dis Info,2015,28(5):288-291.(in Chinese)臧红,刘鸿凌,郝玉清,等.慢加急性肝衰竭并发感染的危险因素及对近期预后的影响[J].传染病信息,2015,28(5):288-291.
|
[4]HU SY,CHEN YW,PAN ZQ,et al.Risk factors of liver failurerelated hospital infection in China:a meta-analysis[N].Acta Acad Med Zunyi,2014,37(5):520-528.(in Chinese)胡世芸,陈妍雯,潘宗琴.我国肝衰竭医院感染危险因素的Meta分析[J].遵义医学院学报,2014,37(5):520-528.
|
[5]GAO LH,NIE QH.Research advances in clinical infection secondary to liver failure[J].Chin Hepatol,2013,18(1):61-62.(in Chinese)高禄化,聂青和.肝衰竭继发临床感染进展[J].肝脏,2013,18(1):61-62.
|
[6]YE SC,SUN BL,WU WY,et al.Risk factors analysis of liver cirrhosis combined with hospital infection in elderly patients[J].Clin Med Eng,2015,22(2):247-248.(in Chinese)叶石才,孙碧兰,吴巍芸,等.老年肝硬化患者合并医院感染危险因素分析[J].临床医学工程,2015,22(2):247-248.
|
[7]WANG JJ.Analysis of pathogenic species causing nosocomial respiratory tract infections and their drug resistance[J].J Pathog Biol,2015,10(6):555-557.(in Chinese)王继军.医院呼吸道感染病原菌种类及其耐药性分析[J].中国病原生物学杂志,2015,10(6):555-557.
|
[8]Chinese Society of Respiratory Diseases&Chinese Society of Pediatrics,Chinese Medical Association.Chinese expert consensus on antiviral treatment and prophylactic administration of antiviral drugs for influenza[J].Clin Education Gen Pract,2016,14(2):124-130.(in Chinese)中华医学会呼吸病学分会,中华医学会儿科学分会.流行性感冒抗病毒药物治疗与预防应用中国专家共识[J].全科医学临床与教育,2016,14(2):124-130.
|
[9] National Health and Family Planning Commission of the People's Republic of China.Diagnostic and treatment protocol for human infections with avian influenza A(H7N9)virus(edition 2014)[J].Chin J Clin Infect Dis,2014,7(1):1-3.(in Chinese)中华人民共和国国家卫生和计划生育委员会.人感染H7N9禽流感诊疗方案(2014年版)[J].中华临床感染病杂志,2014,7(1):1-3.
|
[10] Expert Group for Compilation of Guidelines for Diagnosis and Treatment of Influenza,Ministry of Health.Guidelines for the diagnosis and treatment of influenza(2011)[J].Chin J Tuberc Respir Dis,2011,34(10):725-734.(in Chinese)卫生部流行性感冒诊断与治疗指南编撰专家组.流行性感冒诊断与治疗指南(2011年版)[J].中华结核和呼吸杂志,2011,34(10):725-734.
|
[11]TREANOR JJ,HAYDEN FG,VROOMAN PS,et al.Efficacy and safely of the oral neuraminidase inhibitor oseltamivir in treating acute influenza:a randomized controlled trial[J].JAMA,2000,283(8):1016-1024.
|